← Inspire Medical Systems, Inc.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.6m |
$50.6m
+77.10%
|
$82.0m
+62.18%
|
$115.4m
+40.62%
|
$233.4m
+102.28%
|
$407.9m
+74.75%
|
$624.8m
+53.19%
|
$802.8m
+28.49%
|
$912.0m
+13.60%
|
$898.7m
-1.45%
|
|
| Cost of goods sold | $6.0m |
$10.1m
+67.10%
|
$13.6m
+35.67%
|
$17.6m
+29.17%
|
$33.3m
+88.84%
|
$66.1m
+98.67%
|
$96.6m
+46.07%
|
$123.0m
+27.35%
|
$133.2m
+8.33%
|
$124.6m
-6.45%
|
|
| Gross profit | $22.5m |
$40.5m
+79.77%
|
$68.4m
+68.75%
|
$97.8m
+42.91%
|
$200.1m
+104.70%
|
$341.7m
+70.77%
|
$528.2m
+54.57%
|
$679.8m
+28.70%
|
$778.8m
+14.55%
|
$774.1m
-0.60%
|
|
| Research and development | $6.2m | $7.4m | $12.8m | $26.1m | $37.4m | $68.6m | $116.5m | $114.1m | $103.2m | $99.7m | |
| Selling, general and administrative | $32.4m | $53.5m | $90.5m | $127.9m | $202.6m | $320.7m | $452.0m | $529.6m | $624.6m | $620.3m | |
| Total operating expenses | $38.6m | $60.9m | $103.3m | $154.0m | $240.0m | $389.3m | $568.5m | $643.7m | $727.8m | $720.0m | |
| Operating income (loss) | ($16.0m) |
($20.4m)
-27.34%
|
($34.9m)
-71.25%
|
($56.2m)
-61.07%
|
($39.9m)
+29.10%
|
($47.6m)
-19.43%
|
($40.3m)
+15.38%
|
$36.1m
+189.60%
|
$51.0m
+41.21%
|
$54.1m
+6.22%
|
|
| Interest expense | $1.8m | $3.3m | $2.1m | $2.1m | $2.1m | $1.7m | $0 | $22k | $137k | $26k | |
| Unrealized gain (loss) on investments | $0 | ($52k) | $154k | ($73k) | ($84k) | ($120k) | $746k | ($199k) | $224k | — | |
| Other expense, net | ($42k) | $16k | ($12k) | ($145k) | $117k | $49k | $195k | $855k | $2.7m | — | |
| Total other income | $1.5m | $1.4m | ($1.7m) | $880k | $2.1m | ($3.3m) | ($20.4m) | ($22.4m) | ($14.7m) | — | |
| Income (loss) before income taxes | ($17.5m) | ($21.8m) | ($33.2m) | ($57.1m) | ($42.0m) | ($44.3m) | ($19.9m) | $58.5m | $65.7m | — | |
| Income tax (benefit) expense | $0 | $0 | $40k | $115k | $72k | $613k | $1.2m | $4.9m | ($79.7m) | — | |
| Net income (loss) | ($17.5m) |
($21.8m)
-24.65%
|
($33.2m)
-52.30%
|
($57.2m)
-72.08%
|
($42.0m)
+26.50%
|
($44.9m)
-6.75%
|
($21.2m)
+52.87%
|
$53.5m
+352.96%
|
$145.4m
+171.77%
|
$135.0m
-7.14%
|
|
| Basic (in dollars per share) | — | — | ($1.40) | ($2.19) | ($1.54) | ($1.60) | ($0.72) | $1.80 | $4.95 | — | |
| Diluted (in dollars per share) | — | — | ($1.40) | ($2.19) | ($1.54) | ($1.60) | ($0.72) | $1.75 | $4.89 | — | |
| Interest and dividend income | — | — | — | ($1.1m) |
($125k)
+88.55%
|
($5.0m)
-3940.00%
|
($20.6m)
-307.13%
|
($23.2m)
-13.07%
|
($17.5m)
+24.57%
|
— | |
| Foreign currency translation (loss) gain | — | — | — | $0 | $0 | $89k | $140k | ($65k) | ($296k) | — | |
| Total comprehensive income (loss) | ($17.5m) | ($21.9m) | ($33.1m) | ($57.3m) | ($42.1m) | ($44.9m) | ($20.3m) | $53.2m | $145.3m | — |